- Home
- PED vs CNTB Comparison
PED vs CNTB Comparison
Compare PED & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PED
- CNTB
- Stock Information
- Founded
- PED N/A
- CNTB 2012
- Country
- PED United States
- CNTB United States
- Employees
- PED N/A
- CNTB N/A
- Industry
- PED Oil & Gas Production
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- PED Energy
- CNTB Health Care
- Exchange
- PED Nasdaq
- CNTB Nasdaq
- Market Cap
- PED 48.8M
- CNTB 44.2M
- IPO Year
- PED N/A
- CNTB 2021
- Fundamental
- Price
- PED $0.64
- CNTB N/A
- Analyst Decision
- PED Strong Buy
- CNTB Strong Buy
- Analyst Count
- PED 2
- CNTB 2
- Target Price
- PED $1.63
- CNTB $7.50
- AVG Volume (30 Days)
- PED 572.7K
- CNTB 103.1K
- Earning Date
- PED 08-13-2025
- CNTB 05-15-2025
- Dividend Yield
- PED N/A
- CNTB N/A
- EPS Growth
- PED 2248.88
- CNTB N/A
- EPS
- PED 0.19
- CNTB N/A
- Revenue
- PED $40,173,000.00
- CNTB $26,033,000.00
- Revenue This Year
- PED N/A
- CNTB N/A
- Revenue Next Year
- PED $5.99
- CNTB N/A
- P/E Ratio
- PED $3.36
- CNTB N/A
- Revenue Growth
- PED 30.70
- CNTB N/A
- 52 Week Low
- PED $0.47
- CNTB $0.51
- 52 Week High
- PED $1.10
- CNTB $1.60
- Technical
- Relative Strength Index (RSI)
- PED 51.04
- CNTB 72.64
- Support Level
- PED $0.63
- CNTB $1.02
- Resistance Level
- PED $0.67
- CNTB $1.07
- Average True Range (ATR)
- PED 0.05
- CNTB 0.09
- MACD
- PED -0.01
- CNTB 0.01
- Stochastic Oscillator
- PED 22.62
- CNTB 91.19
About PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.